396 related articles for article (PubMed ID: 28101726)
1. Development of Timolol-Loaded Galactosylated Chitosan Nanoparticles and Evaluation of Their Potential for Ocular Drug Delivery.
Zhao R; Li J; Wang J; Yin Z; Zhu Y; Liu W
AAPS PharmSciTech; 2017 May; 18(4):997-1008. PubMed ID: 28101726
[TBL] [Abstract][Full Text] [Related]
2. Bioadhesive chitosan-loaded liposomes: A more efficient and higher permeable ocular delivery platform for timolol maleate.
Tan G; Yu S; Pan H; Li J; Liu D; Yuan K; Yang X; Pan W
Int J Biol Macromol; 2017 Jan; 94(Pt A):355-363. PubMed ID: 27760378
[TBL] [Abstract][Full Text] [Related]
3. New mucoadhesive chitosan film for ophthalmic drug delivery of timolol maleate: in vivo evaluation.
Fulgêncio Gde O; Viana FA; Ribeiro RR; Yoshida MI; Faraco AG; Cunha-Júnior Ada S
J Ocul Pharmacol Ther; 2012 Aug; 28(4):350-8. PubMed ID: 22320419
[TBL] [Abstract][Full Text] [Related]
4. Chitosan nanoparticles amplify the ocular hypotensive effect of cateolol in rabbits.
Ameeduzzafar ; Ali J; Bhatnagar A; Kumar N; Ali A
Int J Biol Macromol; 2014 Apr; 65():479-91. PubMed ID: 24530326
[TBL] [Abstract][Full Text] [Related]
5. Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation.
Huang J; Peng T; Li Y; Zhan Z; Zeng Y; Huang Y; Pan X; Wu CY; Wu C
AAPS PharmSciTech; 2017 Nov; 18(8):2919-2926. PubMed ID: 28429294
[TBL] [Abstract][Full Text] [Related]
6. Liposome incorporated ion sensitive in situ gels for opthalmic delivery of timolol maleate.
Yu S; Wang QM; Wang X; Liu D; Zhang W; Ye T; Yang X; Pan W
Int J Pharm; 2015 Mar; 480(1-2):128-36. PubMed ID: 25615987
[TBL] [Abstract][Full Text] [Related]
7. The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case.
Battistini FD; Tártara LI; Boiero C; Guzmán ML; Luciani-Giaccobbe LC; Palma SD; Allemandi DA; Manzo RH; Olivera ME
Eur J Pharm Sci; 2017 Jul; 105():188-194. PubMed ID: 28506871
[TBL] [Abstract][Full Text] [Related]
8. Exploring gelatin nanoparticles as novel nanocarriers for Timolol Maleate: Augmented in-vivo efficacy and safe histological profile.
Shokry M; Hathout RM; Mansour S
Int J Pharm; 2018 Jul; 545(1-2):229-239. PubMed ID: 29709617
[TBL] [Abstract][Full Text] [Related]
9. Development of Timolol Maleate Loaded Chitosan Nanoparticles For Improved Ocular Delivery.
Saroha A; Pandey P; Kaushik D
Pharm Nanotechnol; 2017; 5(4):310-316. PubMed ID: 28847270
[TBL] [Abstract][Full Text] [Related]
10. Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: In vitro, ex vivo and toxicity assessments.
Shahab MS; Rizwanullah M; Alshehri S; Imam SS
Int J Biol Macromol; 2020 Nov; 163():2392-2404. PubMed ID: 32979440
[TBL] [Abstract][Full Text] [Related]
11. Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma.
Li J; Tian S; Tao Q; Zhao Y; Gui R; Yang F; Zang L; Chen Y; Ping Q; Hou D
Int J Nanomedicine; 2018; 13():3975-3987. PubMed ID: 30022821
[TBL] [Abstract][Full Text] [Related]
12. Novel ophthalmic timolol meleate liposomal-hydrogel and its improved local glaucomatous therapeutic effect in vivo.
Zhang HH; Luo QH; Yang ZJ; Pan WS; Nie SF
Drug Deliv; 2011; 18(7):502-10. PubMed ID: 21790329
[TBL] [Abstract][Full Text] [Related]
13. In Situ Gelling Electrospun Ocular Films Sustain the Intraocular Pressure-Lowering Effect of Timolol Maleate: In Vitro, Ex Vivo, and Pharmacodynamic Assessment.
Andreadis II; Karavasili C; Thomas A; Komnenou A; Tzimtzimis M; Tzetzis D; Andreadis D; Bouropoulos N; Fatouros DG
Mol Pharm; 2022 Jan; 19(1):274-286. PubMed ID: 34877863
[TBL] [Abstract][Full Text] [Related]
14. Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane.
Singh KH; Shinde UA
Pharmazie; 2011 Aug; 66(8):594-9. PubMed ID: 21901982
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery.
Maulvi FA; Lakdawala DH; Shaikh AA; Desai AR; Choksi HH; Vaidya RJ; Ranch KM; Koli AR; Vyas BA; Shah DO
J Control Release; 2016 Mar; 226():47-56. PubMed ID: 26860285
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation.
Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
J Drug Target; 2010 May; 18(4):292-302. PubMed ID: 19943753
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery.
Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G
J Drug Target; 2011 Jul; 19(6):409-17. PubMed ID: 20678034
[TBL] [Abstract][Full Text] [Related]
18. A potential in situ gel formulation loaded with novel fabricated poly(lactide-co-glycolide) nanoparticles for enhancing and sustaining the ophthalmic delivery of ketoconazole.
Ahmed TA; Aljaeid BM
Int J Nanomedicine; 2017; 12():1863-1875. PubMed ID: 28331311
[TBL] [Abstract][Full Text] [Related]
19. Chitosan nanoparticles for prolonged delivery of timolol maleate.
Agnihotri SA; Aminabhavi TM
Drug Dev Ind Pharm; 2007 Nov; 33(11):1254-62. PubMed ID: 18058322
[TBL] [Abstract][Full Text] [Related]
20. Fabrication and Characterization of Timolol Maleate and Brinzolamide Loaded Nanostructured Lipid Carrier System for Ocular Drug Delivery.
Shrivastava N; Khan S; Baboota S; Ali J
Curr Drug Deliv; 2018; 15(6):829-839. PubMed ID: 29189155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
